Management of Impetigo on the Scalp or Face in Children and Adolescents
For limited scalp or facial impetigo (up to 100 cm² total area), apply topical mupirocin 2% ointment three times daily for 5–7 days as first-line therapy; for extensive disease, multiple lesions, or when topical therapy is impractical, prescribe oral cephalexin 25–50 mg/kg/day divided into 3–4 doses for 7 days. 1, 2, 3
Treatment Algorithm Based on Disease Extent
Limited Disease (≤100 cm² or ≤10 lesions)
Topical mupirocin 2% ointment applied three times daily for 5–7 days is the preferred first-line treatment, achieving cure rates 6-fold higher than placebo and superior to oral antibiotics for localized impetigo. 1, 3, 4
Retapamulin 1% ointment applied twice daily for 5 days is an effective alternative for patients aged 9 months or older, covering up to 100 cm² in adults or 2% total body surface area in children. 1, 5
Before applying topical antibiotics, gently wash the affected area with soap and water to remove crusts and enhance antibiotic penetration. 1
Extensive Disease (>100 cm², multiple sites, or impractical topical therapy)
Oral cephalexin is the first-line systemic antibiotic at 25–50 mg/kg/day divided into 3–4 doses for 7 days (maximum 2 g/day), providing coverage for both Staphylococcus aureus and Streptococcus pyogenes. 1, 2, 3
Dicloxacillin 25–50 mg/kg/day divided into 4 doses for 7 days is an alternative first-line option for methicillin-susceptible S. aureus (MSSA). 2, 3
Amoxicillin-clavulanate is an acceptable alternative when cephalexin or dicloxacillin are not suitable, though it should not be used alone without the clavulanate component. 1, 2
When to Suspect and Treat MRSA
Consider MRSA empirically when lesions exhibit purulent drainage, prior standard treatment has failed, or community CA-MRSA prevalence exceeds 10%. 1, 2
For suspected or confirmed MRSA, switch to clindamycin 20–30 mg/kg/day divided into 3 doses for 7 days as the preferred MRSA-active agent. 1, 2, 3
Trimethoprim-sulfamethoxazole 8–12 mg/kg/day (trimethoprim component) divided into 2 doses for 7 days is an alternative MRSA-active option. 1, 2, 3
Doxycycline 2–4 mg/kg/day divided into 2 doses for 7 days may be used only in children over 8 years of age due to the risk of permanent dental staining. 1, 2, 3
Never use cephalexin, dicloxacillin, or any beta-lactam antibiotic when MRSA is documented or strongly suspected, as these agents lack activity against MRSA. 2, 3
Critical Treatment Considerations and Common Pitfalls
Penicillin alone is seldom effective and should only be used when cultures confirm streptococci alone, as it lacks adequate coverage against S. aureus, which is now the predominant causative organism. 1, 2
Oral antibiotic therapy requires a full 7-day course, not the shorter 5-day course used for topical agents, to prevent treatment failure and recurrence. 1, 2, 3
Do not prescribe oral antibiotics for limited disease when topical mupirocin is appropriate and more effective, as this unnecessarily increases systemic antibiotic exposure and resistance development. 1, 2
Macrolide agents such as erythromycin and azithromycin show rising resistance rates and should be used only with caution or when other options are unavailable. 2, 6
Infection Control Measures to Prevent Spread
Keep draining lesions covered with clean, dry bandages to prevent transmission to others. 1, 2
Encourage frequent hand-washing with soap and water, especially after touching lesions. 1, 2
Do not share towels, washcloths, clothing, or bedding with other household members until the treatment course is finished. 1
Keep the child home from school, daycare, and organized sports until at least 24 hours after initiating antibiotic treatment. 1
Avoid participation in close-contact sports and swimming pools until lesions are fully healed and no longer draining. 1
When to Obtain Cultures and Re-evaluate
Obtain cultures of vesicle fluid, pus, or erosions if there is treatment failure, MRSA is suspected, or in cases of recurrent infections, and adjust antimicrobial therapy based on susceptibility results. 3
Re-evaluate if no improvement occurs after 48–72 hours of appropriate therapy, as this may indicate MRSA, treatment failure, or an alternative diagnosis. 3
Special Populations
For patients with penicillin allergy (non-immediate hypersensitivity), cephalexin may be used as cross-reactivity is less than 5%. 2
For patients with immediate hypersensitivity reactions (anaphylaxis, angioedema, urticaria), use clindamycin instead of any beta-lactam antibiotic. 2
Patients with diabetes or immunosuppression may require a lower threshold for systemic antibiotics and consideration of hospital admission if extensive disease or systemic signs are present. 2